NPI: 1508334129 · TAZEWELL, TN 37879 · Family Nurse Practitioner · NPI assigned 11/13/2018
| Authorized Official | MARTIN, DANIEL (CEO) |
| Parent Organization | ADO INC. |
| NPI Enumeration Date | 11/13/2018 |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 2,303 | $55K |
| 2020 | 5,431 | $98K |
| 2021 | 23,274 | $371K |
| 2022 | 26,335 | $447K |
| 2023 | 20,986 | $456K |
| 2024 | 18,821 | $418K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 26,277 | 22,275 | $816K | |
| 87635 | 13,959 | 12,088 | $556K | |
| 87804 | 21,999 | 9,440 | $198K | |
| 99203 | 1,784 | 1,457 | $82K | |
| 87880 | 7,442 | 6,527 | $69K | |
| 99202 | 1,659 | 1,529 | $55K | |
| 96372 | 3,292 | 2,135 | $32K | |
| 99214 | 306 | 242 | $12K | |
| 87502 | 217 | 186 | $8K | |
| 87651 | 230 | 219 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 18 | 17 | $5K |
| 81001 | 968 | 829 | $2K | |
| 99212 | 58 | 48 | $1K | |
| 36415 | 755 | 633 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 959 | 795 | $447.17 |
| 99211 | 21 | 21 | $163.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 97 | 74 | $150.34 |
| 99000 | 6,296 | 5,598 | $7.16 | |
| 99072 | 10,813 | 9,095 | $0.00 |